Product Information
DARIFENACIN ER 15 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4394 per EA under NDC 33342027710. Its NADAC has been published 375 times since Mar 14, 2018.
FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Darifenacin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342027710
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
DARIFENACIN HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207302FDA Approved
7/28/2017
TE Code
AB
On Market Since
7/29/2017
Pharmacological Classes
Price Statistics
The NADAC for DARIFENACIN ER 15 MG TABLET has been published 375 times since Mar 14, 2018, and over the history we have for it it has declined 93.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4394 per EA |
|---|---|
| All-time high | $6.3836 (Mar 14, 2018) |
| All-time low | $0.3150 (Mar 19, 2025) |
| Median price | $2.0143 |
| Average price | $2.3118 |
| Largest weekly change | +137.4% (Jun 23, 2021) |
| Weeks tracked | 375 |
| Tracking since | Mar 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-71.4%
5Y
-76.6%
All
-93.1%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Darifenacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DARIFENACIN ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 15 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.4394 per EA (NDC 33342027710), effective May 14, 2025.
How has the price of DARIFENACIN ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARIFENACIN ER 15 MG TABLET has declined 93.1%. It has been tracked across 375 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 15 MG TABLET?
Since Mar 14, 2018, the NADAC for DARIFENACIN ER 15 MG TABLET has ranged from a low of $0.3150 (Mar 19, 2025) to a high of $6.3836 (Mar 14, 2018), with a median of $2.0143 per EA.
Are there cheaper alternatives to DARIFENACIN ER 15 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DARIFENACIN ER 15 MG TABLET, is $0.4323 per EA — about 2% below DARIFENACIN ER 15 MG TABLET.
Who manufactures DARIFENACIN ER 15 MG TABLET?
DARIFENACIN ER 15 MG TABLET (NDC 33342027710) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.